Neil Chua

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada et al. · Journal of Clinical Oncology · 2017 · 424 citations

Medicine, Hematology, Oncology +12

Randomized Controlled Trial of the Effects of Aerobic Exercise on Physical Functioning and Quality of Life in Lymphoma Patients

Kerry S. Courneya, Christopher M. Sellar, Clare Stevinson et al. · Journal of Clinical Oncology · 2009 · 372 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +17

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

Laurie H. Sehn, Neil Chua, Marek Trněný et al. · The Lancet Oncology · 2016 · 343 citations

Medicine, Oncology, Pharmacology +13

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Kerry S. Courneya, Janette L. Vardy, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2025 · 256 citations

Medicine, Health Education, Oncology +17